OCT APPLIED FOR REGULATORY APPROVAL FOR A STUDY IN PATIENTS WITH INFECTION DISEASES

This is a multicenter, randomized, double-blind, placebo-controlled study, which is aimed to evaluate the efficacy and safety of a drug for treatment of acute viral respiratory infections and flu in adults vs. placebo.

The study participants are male and female patients, aged from 18 to 65. Overall, 484 patients are to be enrolled. The duration of the therapy is 5 days.
 
In this project OCT will be responsible for site management, project management, monitoring, documentation development, regulatory and logistics activities, data management and statistics.


Aug 22, 2019

Back to the list